• Explore /
  • Poster
  • / Changes in p16INK4a (p16) expression, a biomarker of aging, in peripheral blood T-cells (PBTC) in patients receiving anthracycline (A) vs non-anthracycline (NoA) chemotherapy (CRx) for early-stage breast cancer (EBC).

Changes in p16INK4a (p16) expression, a biomarker of aging, in peripheral blood T-cells (PBTC) in patients receiving anthracycline (A) vs non-anthracycline (NoA) chemotherapy (CRx) for early-stage breast cancer (EBC).

Abstract Poster

Authors

null

Shlomit Strulov Shachar

Rambam Health Care Campus, Haifa, Israel

Shlomit Strulov Shachar , Allison Mary Deal , Natalia Mitin , Kirsten A Nyrop , Jordan T Lee , Seul Ki Choi , Will Pulley , Emily Fox Bell , Nora Christopher , Grant Richard Williams , Lisa A. Carey , Carey K. Anders , Trevor Augustus Jolly , Elizabeth Claire Dees , Katherine Elizabeth Reeder-Hayes , Hanna Kelly Sanoff , Norman E. Sharpless , Hyman B. Muss

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Survivorship

Citation

J Clin Oncol 35, 2017 (suppl; abstr 10060)

DOI

10.1200/JCO.2017.35.15_suppl.10060

Abstract #

10060

Poster Bd #

49

Abstract Disclosures

Similar Posters

First Author: Rahma Ben Ayed

First Author: Kay T Yeung

First Author: Pamela N. Munster

Poster

2019 ASCO Annual Meeting

Risk stratification in earl- stage luminal breast cancer patients treated with and without RT.

Risk stratification in earl- stage luminal breast cancer patients treated with and without RT.

First Author: Charlotta Wadsten